Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy BIO-key International stock | $3.05

Learn how to easily invest in BIO-key International stock.

BIO-key International Inc
NASDAQ: BKYI - USD
SECURITY & PROTECTION SERVICES
$3.05
- $0.15 ( - 4.69%)

BIO-key International Inc is a security & protection services business based in the US. BIO-key International shares (BKYI) are listed on the NASDAQ and all prices are listed in US Dollars. BIO-key International employs 34 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in BIO-key International

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BKYI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

BIO-key International stock price (NASDAQ: BKYI)

Use our graph to track the performance of BKYI stocks over time.

BIO-key International shares at a glance

Information last updated 2021-10-18.
Latest market close$3.05
52-week range$2.75 - $5.17
50-day moving average $3.31
200-day moving average $3.45
Wall St. target price$6.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.90

Buy BIO-key International shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
N/A
$20 per year
N/A
Financial advice powered by relationships, not commissions.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy BIO-key International stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

BIO-key International price performance over time

Historical closes compared with the close of $3.05 from 2021-10-22

1 week (2021-10-15) -5.57%
1 month (2021-09-24) -13.11%
3 months (2021-07-23) -6.73%
6 months (2021-04-23) -8.68%
1 year (2020-10-23) 573.29%
2 years (2019-10-23) 384.13%
3 years (2018-10-23) 167.54%
5 years (2016-10-21) 1,029.63%

BIO-key International financials

Revenue TTM $4.9 million
Gross profit TTM $2 million
Return on assets TTM -20.88%
Return on equity TTM -69.95%
Profit margin -137.98%
Book value $2.37
Market capitalisation $25.3 million

TTM: trailing 12 months

Shorting BIO-key International shares

There are currently 247,870 BIO-key International shares held short by investors – that's known as BIO-key International's "short interest". This figure is 16.3% down from 296,282 last month.

There are a few different ways that this level of interest in shorting BIO-key International shares can be evaluated.

BIO-key International's "short interest ratio" (SIR)

BIO-key International's "short interest ratio" (SIR) is the quantity of BIO-key International shares currently shorted divided by the average quantity of BIO-key International shares traded daily (recently around 1.1 million). BIO-key International's SIR currently stands at 0.22. In other words for every 100,000 BIO-key International shares traded daily on the market, roughly 220 shares are currently held short.

However BIO-key International's short interest can also be evaluated against the total number of BIO-key International shares, or, against the total number of tradable BIO-key International shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case BIO-key International's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 BIO-key International shares in existence, roughly 30 shares are currently held short) or 0.0367% of the tradable shares (for every 100,000 tradable BIO-key International shares, roughly 37 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against BIO-key International.

Find out more about how you can short BIO-key International stock.

BIO-key International share dividends

We're not expecting BIO-key International to pay a dividend over the next 12 months.

Have BIO-key International's shares ever split?

BIO-key International's shares were split on a 1:8 basis on 19 November 2020. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your BIO-key International shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for BIO-key International shares which in turn could have impacted BIO-key International's share price.

BIO-key International share price volatility

Over the last 12 months, BIO-key International's shares have ranged in value from as little as $2.75 up to $5.17. A popular way to gauge a stock's volatility is its "beta".

BKYI.US volatility(beta: 0.94)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BIO-key International's is 0.936. This would suggest that BIO-key International's shares are less volatile than average (for this exchange).

BIO-key International overview

BIO-key International, Inc. , together with its subsidiaries, develops and markets fingerprint identification biometric technology, enterprise-ready identity access management solutions, and software solutions to commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premise SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc.

Frequently asked questions

What percentage of BIO-key International is owned by insiders or institutions?
Currently 8.386% of BIO-key International shares are held by insiders and 7.184% by institutions.
How many people work for BIO-key International?
Latest data suggests 34 work at BIO-key International.
When does the fiscal year end for BIO-key International?
BIO-key International's fiscal year ends in December.
Where is BIO-key International based?
BIO-key International's address is: Building A, Wall, NJ, United States, 07719
What is BIO-key International's ISIN number?
BIO-key International's international securities identification number is: US09060C4087
What is BIO-key International's CUSIP number?
BIO-key International's Committee on Uniform Securities Identification Procedures number is: 09060C101

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site